Pharmaceutical

Ascential Medical & Life Sciences Announces Executive Leadership Changes to Drive Strategic Growth

Ellen Scipta and Chris Cowen join the organization as CFO and CCO, respectively, while Todd Martensen transitions from CCO to…

9 months ago

Medrio Enhances RTSM For Faster Clinical Trial Starts and Greater Flexibility

SAN FRANCISCO, March 26, 2025 /PRNewswire/ -- Medrio, a global leader in clinical trial technology, today announced enhancements to its randomization…

9 months ago

Corundum Systems Biology Supports Expansion of World’s Deepest Multiomic Dataset into Japan

Pheno.AI's Human Phenotype Project (HPP) to Catalyze the Future of AI-Driven Health with Japanese Cohort TOKYO, March 26, 2025 /PRNewswire/…

9 months ago

Pleio Unveils OLLIE™: AI That Listens, Learns, and Guides To Elevate Human Connection in Patient Medication Journeys

OLLIE integrates with Pleio's GoodStart program and supports pharmaceutical companies in earlier identification and understanding of patient sentiment and confidence…

9 months ago

Rice Biotech Launch Pad and RBL LLC to celebrate official launch and lab opening

Presidential lecture to be delivered by Robert Langer at Rice followed by RBL LLC launch event with keynote presentation by Robert…

9 months ago

Rarecells Inc. Appoints Dr. Neil Kurtz to Board of Directors

NEW YORK and PARIS, March 26, 2025 /PRNewswire/ -- Rarecells Inc., a pioneering company in liquid biopsy technology, is pleased…

9 months ago

DATAcc by DiMe Releases Resources to Build the Business Case for Digital Endpoints

New tools will calculate the ROI of using digital endpoints in clinical trials, empowering greater innovation in research BOSTON, March…

9 months ago

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc.…

9 months ago

Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical Trial Evaluating Brelovitug (BJT-778) as a Monotherapy Treatment for Chronic Hepatitis D

AZURE-1 will evaluate the efficacy and safety of brelovitug compared to delayed treatmentREDWOOD CITY, Calif., March 26, 2025 (GLOBE NEWSWIRE)…

9 months ago

MBX Biosciences to Participate in the 24th Annual Needham Virtual Healthcare Conference

CARMEL, Ind., March 26, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the…

9 months ago